Brought to you by 
AMAG nets $165.9mm through a follow-on public offering
26 Apr 2021
Executive Summary
AMAG Pharmaceuticals (anemia therapeutic and cardiovascular and oncology imaging agents) has netted $165.9mm through the follow-on public offering of 3.6mm common shares at $48.25 apiece. The company had originally planned to sell 3mm shares.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AMAG nets $165.9mm through a follow-on public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice